Meningococcal vaccination

Meningococcal vaccination represents a preventive immunization indication rather than an intrinsic disease entity, functioning as an active prophylaxis against invasive disease caused by the encapsulated bacterium *Neisseria meningitidis*

Meningococcal vaccination represents a preventive immunization indication rather than an intrinsic disease entity, functioning as an active prophylaxis against invasive disease caused by the encapsulated bacterium *Neisseria meningitidis* It primarily targets the central nervous and cardiovascular systems by defending against life-threatening bacterial meningitis and fulminant meningococcemia Pathophysiologically, the bacteria can breach the nasopharyngeal mucosal barrier to cause intravascular ...

It primarily targets the central nervous and cardiovascular systems by defending against life-threatening bacterial meningitis and fulminant meningococcemia

It primarily targets the central nervous and cardiovascular systems by defending against life-threatening bacterial meningitis and fulminant meningococcemia

This preventive indication is routinely applied to adolescents and young adults, as well as high-risk populations across all ages, including individuals with anatomic or functional asplenia, persistent complement deficiencies, or HIV infection

This preventive indication is routinely applied to adolescents and young adults, as well as high-risk populations across all ages, including individuals with anatomic or functional asplenia, persistent complement deficiencies, or HIV infection

This preventive indication is routinely applied to adolescents and young adults, as well as high-risk populations across all ages, including individuals with anatomic or functional asplenia, persistent complement deficiencies, or HIV infection